Palisade Bio, Inc. (PALI)
NASDAQ·Healthcare·Biotechnology
$1.96
-3.22%
Mkt Cap $338.48M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
Implied Upside
-23.3%
Consensus $1.50 vs current $1.96
NASDAQ·Healthcare·Biotechnology
$1.96
-3.22%
Mkt Cap $338.48M
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
-23.3%
Consensus $1.50 vs current $1.96